Nath Bio-Genes (India) Ltd.

NSE: NATHBIOGEN | BSE: 537291

Risky Value

Download real time

162.65 3.53 (2.22%)

38.46% Fall from 52W High

22,213 NSE+BSE Volume

NSE 05 May, 2025 3:41 PM (IST)

309.1

Market Cap

Below industry Median

1.2

Beta 1Year

High Volatility

Nath Bio-Genes (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Nath Bio-Genes (India) Ltd. on BSE

Search Inside the pdf :

Nath Bio-Genes (India) Ltd.

02 May 2025

162.65

2.22%

Earnings Call

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Earning call held on 30th April 2025

Nath Bio-Genes (India) Ltd.

02 May 2025

162.65

2.22%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Revised Disclosure for Resignation of Ms. Ashu Jain from the post of Independent Director of the Company.

Nath Bio-Genes (India) Ltd.

29 Apr 2025

162.65

2.22%

Investor Presentation

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Audited Financial Results as on 31st March 2025

Nath Bio-Genes (India) Ltd.

29 Apr 2025

162.65

2.22%

Result

Nath Bio-Genes (India) Ltd - 537291 - Financial Results As On 31St March 2025

BSE India

The Board in the meeting held today on 29th April 2025 has approved the Standalone and Consolidated Financial Results as on 31st Match 2025.

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	55.83	37.35	43.45	49.5%	28.5%
Operating Profit Qtr	0.41	8.04	3.93	-94.9%	-89.6%
Net Profit Qtr	1.48	2.65	2.62	-44.2%	-43.5%
Earning Per Share Adjusted latest Qtr	0.78	1.39	1.38	-43.9%	-43.5%

* Consolidated data

Detailed Results

Nath Bio-Genes (India) Ltd.

29 Apr 2025

162.65

2.22%

Board Meeting

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

The Board on meeting held today on 29th April 2025 has approved the following. 1. Standalone Audited Financial Results as on 31st March 2025 along with Auditors Report 2. Consolidated Audited Financial Results as on 31st March 2025 along with Auditors Report 3. Other Disclosure/ Announcements.

Nath Bio-Genes (India) Ltd.

24 Apr 2025

162.65

2.22%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Intimation Of Earning Conference Call.

BSE India

Intimation of Con Call to be held on 30th April 2025

Nath Bio-Genes (India) Ltd.

21 Apr 2025

162.65

2.22%

Board Meeting

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Audited Financial Results …

BSE India

Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2025 ,inter alia, to consider and approve Audited Financial Results for the quarter and financial year ended 31st March 2025

Nath Bio-Genes (India) Ltd.

21 Apr 2025

162.65

2.22%

Corp. Note

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Issue of Duplicate share certificate

Nath Bio-Genes (India) Ltd.

14 Apr 2025

162.65

2.22%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under Reg 74(5) of SEBI DP, Regulations- NATHBIOGEN

Nath Bio-Genes (India) Ltd.

27 Mar 2025

162.65

2.22%

SAST

Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window

BSE India

Closure of Trading Window

Is Nath Bio-Genes (India) Ltd. worth buying?

121 Votes:

Buy 83.47%

Sell 11.57%

Hold 4.96%